Literature DB >> 19288585

Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis.

Lan Dai1, Chen Li, Kerby A Shedden, David E Misek, David M Lubman.   

Abstract

The proteomic profiles from two distinct ovarian endometrioid tumor-derived cell lines, (MDAH-2774 and TOV-112D) each with different morphological characteristics and genetic mutations, have been studied. Characterization of the differential global protein expression between these two cell lines has important implications for the understanding of the pathogenesis of ovarian endometrioid carcinoma. In this comparative proteomic study, extensive fractionation of peptides generated from whole-cell trypsin digestion was achieved by coupling cIEF in the first-dimensional separation with capillary LC (RP-HPLC) in the second dimensional separation. Online analysis was performed using tandem mass spectra acquired by a linear ion trap mass spectrometer from triplicate runs. A total of 1749 and 1955 proteins with protein probability above 0.95 were identified from MDAH-2774 and TOV-112D after filtering through Peptide Prophet/Protein Prophet software. Differentially expressed proteins were further investigated by ingenuity pathway analysis (IPA) to reveal the association with important biological functions. Canonical pathway analysis using IPA demonstrates that important signaling pathways are highly associated with one of these two cell lines versus the other, such as the PI3K/AKT pathway, which is found to be significantly predominant in MDAH-2774 but not in TOV-112D. Also, protein network analysis using IPA highlights p53 as a central hub relating to other proteins from the connectivity map. These results illustrate the utility of high throughput proteomics methods using large-scale proteome profiling combined with bioinformatics tools to identify differential signaling pathways, thus contributing to the understanding of mechanisms of deregulation in neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288585      PMCID: PMC2674123          DOI: 10.1002/elps.200800505

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  25 in total

1.  Proteomics in drug discovery.

Authors: 
Journal:  Drug Discov Today       Date:  1999-03       Impact factor: 7.851

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

Review 3.  Computational methods for the comparative quantification of proteins in label-free LCn-MS experiments.

Authors:  Jason W H Wong; Matthew J Sullivan; Gerard Cagney
Journal:  Brief Bioinform       Date:  2007-09-28       Impact factor: 11.622

4.  Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.

Authors:  R Wu; Y Zhai; E R Fearon; K R Cho
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

5.  Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells.

Authors:  K Nishio; T Nakamura; Y Koh; F Kanzawa; T Tamura; N Saijo
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

6.  Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.

Authors:  Monica Brown Jones; Henry Krutzsch; Hungjun Shu; Yingming Zhao; Lance A Liotta; Elise C Kohn; Emmanuel F Petricoin
Journal:  Proteomics       Date:  2002-01       Impact factor: 3.984

7.  Mutation of the PIK3CA gene in ovarian and breast cancer.

Authors:  Ian G Campbell; Sarah E Russell; David Y H Choong; Karen G Montgomery; Marianne L Ciavarella; Christine S F Hooi; Briony E Cristiano; Richard B Pearson; Wayne A Phillips
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

8.  Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers.

Authors:  Haixing Wang; Maureen T Kachman; Donald R Schwartz; Kathleen R Cho; David M Lubman
Journal:  Proteomics       Date:  2004-08       Impact factor: 3.984

9.  A new algorithm using cross-assignment for label-free quantitation with LC-LTQ-FT MS.

Authors:  Victor P Andreev; Lingyun Li; Lei Cao; Ye Gu; Tomas Rejtar; Shiaw-Lin Wu; Barry L Karger
Journal:  J Proteome Res       Date:  2007-04-19       Impact factor: 4.466

10.  Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.

Authors:  P A Curmi; C Noguès; S Lachkar; N Carelle; M P Gonthier; A Sobel; R Lidereau; I Bièche
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  16 in total

1.  Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.

Authors:  Lan Dai; Jintang He; Yashu Liu; Jaeman Byun; Anuradha Vivekanandan; Subramaniam Pennathur; Xing Fan; David M Lubman
Journal:  Proteomics       Date:  2011-10-24       Impact factor: 3.984

2.  Quantitative proteomic profiling studies of pancreatic cancer stem cells.

Authors:  Lan Dai; Chen Li; Kerby A Shedden; Cheong J Lee; Chenwei Li; HuyVuong Quoc; Diane M Simeone; David M Lubman
Journal:  J Proteome Res       Date:  2010-07-02       Impact factor: 4.466

3.  A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

Authors:  Hsin-Yao Tang; Lynn A Beer; Tony Chang-Wong; Rachel Hammond; Phyllis Gimotty; George Coukos; David W Speicher
Journal:  J Proteome Res       Date:  2011-11-18       Impact factor: 4.466

Review 4.  Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis--an update covering the period 2008-2011.

Authors:  Subhashini Selvaraju; Ziad El Rassi
Journal:  Electrophoresis       Date:  2011-11-28       Impact factor: 3.535

Review 5.  Proteomics and ovarian cancer: integrating proteomics information into clinical care.

Authors:  John L Hays; Geoffrey Kim; Iulia Giuroiu; Elise C Kohn
Journal:  J Proteomics       Date:  2010-06-01       Impact factor: 4.044

6.  Capillary isoelectric focusing with pH 9.7 cathode for the analysis of gastric biopsies.

Authors:  Lauren M Ramsay; Nathan Cermak; Oluwatosin O Dada; Norman J Dovichi
Journal:  Anal Bioanal Chem       Date:  2011-04-02       Impact factor: 4.142

7.  PDGF-BB and TGF-{beta}1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress.

Authors:  Ying-Xin Qi; Jun Jiang; Xiao-Hua Jiang; Xiao-Dong Wang; Su-Ying Ji; Yue Han; Ding-Kun Long; Bao-Rong Shen; Zhi-Qiang Yan; Shu Chien; Zong-Lai Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

8.  Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.

Authors:  Lan Dai; Yashu Liu; Jintang He; Callie G Flack; Caroline E Talsma; Jessica G Crowley; Karin M Muraszko; Xing Fan; David M Lubman
Journal:  Proteomics       Date:  2011-09-08       Impact factor: 3.984

9.  On-line amino acid-based capillary isoelectric focusing-ESI-MS/MS for protein digests analysis.

Authors:  Guijie Zhu; Liangliang Sun; Ping Yang; Norman J Dovichi
Journal:  Anal Chim Acta       Date:  2012-04-27       Impact factor: 6.558

10.  Nuclear envelope proteins modulate proliferation of vascular smooth muscle cells during cyclic stretch application.

Authors:  Ying-Xin Qi; Qing-Ping Yao; Kai Huang; Qian Shi; Ping Zhang; Guo-Liang Wang; Yue Han; Han Bao; Lu Wang; Hai-Peng Li; Bao-Rong Shen; Yingxiao Wang; Shu Chien; Zong-Lai Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.